Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin

Abstract excerpt

The identity of the glioblastoma (GBM) cell of origin and its contributions to disease progression and treatment response remain largely unknown. We have analyzed how the phenotypic state of the initially transformed cell affects mouse GBM development and essential GBM cell (GC) properties. We find that GBM induced in neural stem-cell-like glial fibrillary acidic protein (GFAP)-expressing cells in the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Cells and Metastasis
• Share to Glioma Diagnosis and Treatment
• Share to MicroRNA in disease regulation